Compositions and methods for detecting Borrelia afzelii
AssigneeMedical Diagnostic Laboratories, LLC
InventorsMelanie Feola, Martin Adelson, Eli Mordechai, Lisa Novak
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedical Diagnostic Laboratories, LLC
InventorsMelanie Feola, Martin Adelson, Eli Mordechai, Lisa Novak
Estimating the term…
Disclosed are oligonucleotides useful in methods for determining whether a sample contains Borrelia afzelii, a spirochete which is a causative agent of Lyme disease in humans. These oligonucleotides, which have nucleotide sequences derived from a coding segment of the gene encoding the p24 gene for the outer surface protein of Borrelia afzelii, are useful as forward and reverse primers for a polymerase chain reaction using nucleic acids from a biological sample as templates, and as probes for detecting any resultant amplicon. Detection of an amplicon indicates the sample contains Borrelia afzelii. Real-time PCR and detection using florescence resonance energy transfer is disclosed.
A method of detecting the presence of Borrelia afzelii in a biological sample, comprising:
A kit for PCR detection of Borrelia afzelii, comprising:
Dependencies are inferred from the claim text.